Prevalence & Prescription: Prescribing Practices of Clozapine in Australia between 2005 & 2010

Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of refractory schizophrenia in the region. Utili...

Full description

Bibliographic Details
Main Authors: Shae-Leigh C. Vella, Nagesh B. Pai
Format: Article
Language:English
Published: Light House Polyclinic Mangalore 2012-04-01
Series:Online Journal of Health & Allied Sciences
Subjects:
Online Access:http://www.ojhas.org/issue41/2012-1-6.htm
Description
Summary:Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of refractory schizophrenia in the region. Utilising a pharmacoepidemiological approach; the results indicated that only 8.4% of the individuals estimated to be suffering from refractory schizophrenia in the region were prescribed clozapine between 2005 and 2010, with only 4.1% continuing clozapine to the conclusion of the study. In conclusion it is evident that clozapine is widely under-prescribed in this area of Australia.
ISSN:0972-5997